Sign in

CIK 0001799191

  • Accelerated filer
  • Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN STLNW DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843562323
Phone
+1 562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Common stock Nasdaq
  • DFPH Common stock OTC
  1. 4 Open-market buy Director bought 1,000 shares at $10.12 ($10,115)
  2. 4/A Grant or award Chief Executive Officer acquired 353,450 shares (grant or award)
  3. 4/A Exercise or conversion Director acquired 30,000 shares (option exercise)
  4. 4/A Returned to the company Director returned 14,887 shares (to the company)
  5. 4 Conversion Director acquired 100,000 shares (conversion)
  6. 4 Grant or award Chief Medical Officer acquired 28,398 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 118,916 shares (grant or award)
  8. 4 Grant or award Director acquired 4,109,771 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 195,236 shares (grant or award)
  10. 4 Conversion Director acquired 30,000 shares (conversion)
  11. 4 Grant or award Chief Executive Officer acquired 353,450 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Conversion 10% owner acquired 40 shares (conversion)
  14. 4 Conversion 10% owner acquired 85,153 shares (conversion)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 13 of 14 · 270 filings